Skip to main content

Advertisement

SpringerLink
Log in

Generation of mature hematopoietic cells from human pluripotent stem cells

  • Progress in Hematology
  • Disease modeling and treatment by iPS cells
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

A number of malignant and non-malignant hematological disorders are associated with the abnormal production of mature blood cells or primitive hematopoietic precursors. Their capacity for continuous self-renewal without loss of pluripotency and the ability to differentiate into adult cell types from all three primitive germ layers make human embryonic stem cells and induced pluripotent stem cells (hiPSCs) attractive complementary cell sources for large-scale production of transfusable mature blood cell components in cell replacement therapies. The generation of patient-specific hematopoietic stem/precursor cells from iPSCs by the regulated manipulation of various factors involved in reprograming to ensure complete pluripotency, and developing innovative differentiation strategies for generating unlimited supply of clinically safe, transplantable, HLA-matched cells from hiPSCs to outnumber the inadequate source of hematopoietic stem cells obtained from cord blood, bone marrow and peripheral blood, would have a major impact on the field of regenerative and personalized medicine leading to translation of these results from bench to bedside.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Thomas ED. Bone marrow transplantation: a review. Semin Hematol. 1999;36:95–103.

    PubMed  CAS  Google Scholar 

  2. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.

    Article  PubMed  CAS  Google Scholar 

  3. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;25(126):663–76.

    Article  Google Scholar 

  4. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313–7.

    Article  PubMed  CAS  Google Scholar 

  5. Yu J, Vodyanik MA, Smuga-Otto K, Tian S, Stewart R, Slukvin II, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–20.

    Article  PubMed  CAS  Google Scholar 

  6. Lapillonne H, Kobari L, Mazurier C, Tropel P, Giarratana MC, Zanella-Cleon I, et al. Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica. 2010;95:1651–9.

    Article  PubMed  CAS  Google Scholar 

  7. Grskovic M, Javaherian A, Strulovici B, Daley GQ. Induced pluripotent stem cells—opportunities for disease modelling and drug discovery. Nat Rev Drug Discov. 2011;10:915–29.

    PubMed  CAS  Google Scholar 

  8. Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood. 2011;117:e109–19.

    Article  PubMed  CAS  Google Scholar 

  9. Giorgetti A, Montserrat N, Aasen T, Gonzalez F, Rodriguez-Piza I, Vassena R, et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell. 2009;5:353–7.

    Article  PubMed  CAS  Google Scholar 

  10. Broxmeyer HE, Lee MR, Hangoc G, Cooper S, Prasain N, Kim YJ, et al. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood. 2011;117:4773–7.

    Article  PubMed  CAS  Google Scholar 

  11. Moore MA, Shieh JH, Lee G. Hematopoietic cells. Methods Enzymol. 2006;418:208–42.

    Article  PubMed  CAS  Google Scholar 

  12. Park SW, Jun Koh Y, Jeon J, Cho YH, Jang MJ, Kang Y. Efficient differentiation of human pluripotent stem cells into functional CD34+ progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways. Blood. 2010;116:5762–72.

    Article  PubMed  CAS  Google Scholar 

  13. Vodyanik MA, Bork JA, Thomson JA, Slukvin II. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood. 2005;105:617–26.

    Article  PubMed  CAS  Google Scholar 

  14. Vodyanik MA, Thomson JA, Slukvin II. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood. 2006;108:2095–105.

    Article  PubMed  CAS  Google Scholar 

  15. Choi KD, Yu J, Smuga-Otto K, Salvagiotto G, Rehrauer W, Vodyanik M, et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells. 2009;27:559–67.

    PubMed  CAS  Google Scholar 

  16. Feng Q, Lu SJ, Klimanskaya I, Gomes I, Kim D, Chung Y, et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells. 2010;28:704–12.

    Article  PubMed  Google Scholar 

  17. Niwa A, Umeda K, Chang H, Saito M, Okita K, Takahashi K, et al. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors. J Cell Physiol. 2009;221:367–77.

    Article  PubMed  CAS  Google Scholar 

  18. Wang Y, Umeda K, Nakayama N. Collaboration between WNT and BMP signaling promotes hemoangiogenic cell development from human fibroblast-derived iPS cells. Stem Cell Res. 2010;4:223–31.

    Article  PubMed  CAS  Google Scholar 

  19. Chang KH, Bonig H, Papayannopoulou T. Generation and characterization of erythroid cells from human embryonic stem cells and induced pluripotent stem cells: an overview. Stem Cells Int. 2011;2011:791604.

    PubMed  Google Scholar 

  20. Olivier EN, Qiu C, Velho M, Hirsch RE, Bouhassira EE. Large-scale production of embryonic red blood cells from human embryonic stem cells. Exp Hematol. 2006;34:1635–42.

    Article  PubMed  CAS  Google Scholar 

  21. Dias J, Gumenyuk M, Kang H, Vodyanik M, Yu J, Thomson JA, et al. Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev. 2011;20:1639–47.

    Article  PubMed  CAS  Google Scholar 

  22. Lu SJ, Feng Q, Park JS, Vida L, Lee BS, Strausbauch M, et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood. 2008;112:4475–84.

    Article  PubMed  CAS  Google Scholar 

  23. Bruno S, Gunetti M, Gammaitoni L, Dane A, Cavalloni G, Sanavio F, et al. In vitro and in vivo megakaryocyte differentiation of fresh and ex vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution. Haematologica. 2003;88:379–87.

    PubMed  Google Scholar 

  24. Sullenbarger B, Bahng JH, Gruner R, Kotov N, Lasky LC. Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. Exp Hematol. 2009;37:101–10.

    Article  PubMed  CAS  Google Scholar 

  25. Gaur M, Kamata T, Wang S, Moran B, Shattil SJ, Leavitt AD. Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost. 2006;4:436–42.

    Article  PubMed  CAS  Google Scholar 

  26. Takayama N, Nishimura S, Nakamura S, Shimizu T, Ohnishi R, Endo H, et al. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med. 2010;207:2817–30.

    Article  PubMed  CAS  Google Scholar 

  27. Lu SJ, Li F, Yin H, Feng Q, Kimbrel EA, Hahm E, et al. Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res. 2011;21:530–45.

    Article  PubMed  CAS  Google Scholar 

  28. Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, et al. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. J Immunother. 2006;29:545–57.

    Article  PubMed  CAS  Google Scholar 

  29. Tseng SY, Nishimoto KP, Silk KM, Majumdar AS, Dawes GN, Waldmann H, et al. Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells. Regen Med. 2009;4:513–26.

    Article  PubMed  CAS  Google Scholar 

  30. Zhan X, Dravid G, Ye Z, Hammond H, Shamblott M, Gearhart J, et al. Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet. 2004;364:163–71.

    Article  PubMed  Google Scholar 

  31. Choi KD, Vodyanik MA, Slukvin II. Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin−CD34+CD43+CD45+ progenitors. J Clin Invest. 2009;119:2818–29.

    Article  PubMed  CAS  Google Scholar 

  32. Su Z, Frye C, Bae KM, Kelley V, Vieweg J, et al. Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions. Clin Cancer Res. 2008;14:6207–17.

    Article  PubMed  CAS  Google Scholar 

  33. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363:411–22.

    Article  PubMed  CAS  Google Scholar 

  34. Woll PS, Grzywacz B, Tian X, Marcus RK, Knorr DA, Verneris MR, et al. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity. Blood. 2009;113:6094–101.

    Article  PubMed  CAS  Google Scholar 

  35. Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, et al. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. J Virol. 2011;85:43–50.

    Article  PubMed  CAS  Google Scholar 

  36. Saeki K, Saeki K, Nakahara M, Matsuyama S, Nakamura N, Yogiashi Y, et al. A feeder-free and efficient production of functional neutrophils from human embryonic stem cells. Stem Cells. 2009;27:59–67.

    Article  PubMed  CAS  Google Scholar 

  37. Morishima T, Watanabe K, Niwa A, Fujino H, Matsubara H, Adachi S, et al. Neutrophil differentiation from human-induced pluripotent stem cells. J Cell Physiol. 2011;226:1283–91.

    Article  PubMed  CAS  Google Scholar 

  38. Carpenter L, Malladi R, Yang CT, French A, Pilkington KJ, Forsey RW, et al. Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. Blood. 2011;117:4008–11.

    Article  PubMed  CAS  Google Scholar 

  39. Galic Z, Kitchen SG, Kacena A, Subramanian A, Burke B, Cortado R, et al. T lineage differentiation from human embryonic stem cells. Proc Natl Acad Sci USA. 2006;103:11742–7.

    Article  PubMed  CAS  Google Scholar 

  40. Galic Z, Kitchen SG, Subramanian A, Bristol G, Marsden MD, Balamurugan A, et al. Generation of T lineage cells from human embryonic stem cells in a feeder free system. Stem Cells. 2009;27:100–7.

    Article  PubMed  CAS  Google Scholar 

  41. Timmermans F, Velghe I, Vanwalleghem L, De Smedt M, Van Coppernolle S, Taghon T, et al. Generation of T cells from human embryonic stem cell-derived hematopoietic zones. J Immunol. 2009;182:6879–88.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

Authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. National Primate Research Center, University of Wisconsin Graduate School, 1220 Capitol Court, Madison, WI, 53715, USA

    Padma Priya Togarrati

  2. Department of Pathology and Laboratory Medicine, University of Wisconsin Medical School, 600 Highland Ave, Madison, WI, 53792, USA

    Kran Suknuntha

  3. Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand

    Kran Suknuntha

Authors
  1. Padma Priya Togarrati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kran Suknuntha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Padma Priya Togarrati.

About this article

Cite this article

Togarrati, P.P., Suknuntha, K. Generation of mature hematopoietic cells from human pluripotent stem cells. Int J Hematol 95, 617–623 (2012). https://doi.org/10.1007/s12185-012-1094-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-012-1094-x

Keywords

Search

Navigation